HUTCHMED (HCM)

• Market cap: $2.4B
• 1 day: -1.48%
• 5 days: 2.27%
• 1 month: -5.28%
• 3 months: 4.88%
• 6 months: -20.3%
• Year to date: 2.42%
• 1 year: -9.04%
• 5 years: -50.41%
• 10 years: 4.33%
• Sector: Healthcare
• Industry: Drug Manufacturers - Specialty & Generic

About: HUTCHMED (China) Ltd is a biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies world-wide and an extensive commercial infrastructure in its home market, China. The company operates in two reportable segments: Oncology/Immunology and Other Ventures.

Employees: 1,811